Alcon (ALC) Total Non-Current Liabilities (2009 - 2026)
Alcon (ALC) posted Total Non-Current Liabilities of $6.3 billion for Q2 2026, down 2.27% on a QoQ basis from $6.5 billion in Q1 2026, and down 7.29% year-over-year from $6.8 billion in Q2 2025.
Analysis
Alcon (ALC) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Alcon has reported Total Non-Current Liabilities for 11 years, with the latest figure at $6.3 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 7.29% year-over-year to $6.3 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 7.29% decrease from a year earlier, with the FY2025 full-year figure at $6.5 billion, down 0.69% from the prior year.
- Total Non-Current Liabilities was $6.3 billion for Q2 2026 at Alcon, down from $6.5 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $6.9 billion in Q2 2023, with the low at $5.8 billion in Q3 2022.
- Average Total Non-Current Liabilities over 5 years is $6.5 billion, with a median of $6.5 billion recorded in 2026.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities dropped 9.52% in 2022, then advanced 17.01% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $6.8 billion in 2022, then decreased by 2.34% to $6.6 billion in 2023, then declined by 1.15% to $6.5 billion in 2024, then slipped by 0.69% to $6.5 billion in 2025, then decreased by 2.1% to $6.3 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $6.3 billion (Q2 2026), $6.5 billion (Q1 2026), and $6.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.34 Bn |
| Mar 31, 2026 | 6.48 Bn |
| Dec 31, 2025 | 6.47 Bn |
| Sep 30, 2025 | 6.45 Bn |
| Jun 30, 2025 | 6.83 Bn |
| Dec 31, 2024 | 6.52 Bn |
| Sep 30, 2024 | 6.52 Bn |
| Jun 30, 2024 | 6.44 Bn |
| Mar 31, 2024 | 6.47 Bn |
| Dec 31, 2023 | 6.59 Bn |
| Sep 30, 2023 | 6.71 Bn |
| Jun 30, 2023 | 6.86 Bn |
| Mar 31, 2023 | 6.83 Bn |
| Dec 31, 2022 | 6.75 Bn |
| Sep 30, 2022 | 5.82 Bn |
| Jun 30, 2022 | 5.87 Bn |
| Mar 31, 2022 | 6.06 Bn |
| Dec 31, 2021 | 6.27 Bn |
| Sep 30, 2021 | 6.33 Bn |
| Jun 30, 2021 | 6.48 Bn |